The impact of age, HIV serostatus and seroconversion on methamphetamine use

American Journal of Drug and Alcohol Abuse

Volumn 42, Issue 2, 2016, Pages 168-177

  Montoya, Jessica L ^a   Cattie, Jordan ^a   Morgan, Erin ^b   Woods, Steven Paul ^b   Cherner, Mariana ^b   Moore, David J ^b   Atkinson, J Hampton ^b,c   Grant, Igor ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Age; HIV risk behavior; HIV AIDS; Methamphetamine; Stimulant

Indexed keywords

METHAMPHETAMINE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PUBLIC HEALTH; SEROCONVERSION; SUBSTANCE USE; AGING; AMPHETAMINE DEPENDENCE; COMPLICATION; HIGH RISK BEHAVIOR; MIDDLE AGED; PSYCHOLOGY; SERODIAGNOSIS; VIROLOGY; YOUNG ADULT;

ADULT; AGING; AIDS SERODIAGNOSIS; AMPHETAMINE-RELATED DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; RISK-TAKING; SEROCONVERSION; YOUNG ADULT;

EID: 84958047477     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1114625     Document Type: Article

References (50)

1. Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, Jacobson LP. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2007;45:85-92.
2. Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, Dilley J, Klausner JD. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423-1424.
3. Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 1998;88:113-116.
4. Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 1996;13:483-486.
5. Halkitis PN, Green KA, Carragher DJ. Methamphetamine use, sexual behavior, and HIV seroconversion. J Gay Lesb Psychother 2006;10:95-109.
6. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat 2002;22:149-156.
7. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, Group HIVNRC. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003;188:1820-1826.
8. Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care 2012;24:1504-1513.
9. Lohse N, Hansen AB, Gerstoft J, Obel N. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother 2007;60:461-463.
10. Centers for Disease Control and Prevention, 2012. HIV Surveillance Report 2011. Available from: http://www. cdc.gov/hiv/library/reports/surveillance/index.html [last accessed 25 Sept 2014].
11. Gorbach PM, Drumright LN, Daar ES, Little SJ. Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr 2006;42:80-85.
12. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Metaanalysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-453.
13. Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002;16:1529-1535.
14. Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, Little SJ. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr 2011;56:176-182.
15. Vallabhaneni S, McConnell JJ, Loeb L, Hartogensis W, Hecht FM, Grant RM, Pilcher CD. Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. PLoS One 2013;8:e55397.
16. Aidala AA, Lee G, Garbers S, Chiasson MA. Sexual behaviors and sexual risk in a prospective cohort of HIV-positive men and women in New York City, 1994-2002: implications for prevention. AIDS Educ Prev 2006;18:12-32.
17. Pappas MK, Halkitis PN. Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City. AIDS Care 2011;23:1410-1416.
18. Rabkin JG, McElhiney MC, Ferrando SJ. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS 2004;18(Suppl. 1):S43-48.
19. Iudicello JE, Morgan EE, Gongvatana A, Letendre SL, Grant I, Woods SP, Translational Methamphetamine ARCG. Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect? J Neurovirol 2014;20:85-98.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Publishing, Inc.; 2000.
21. World Health Organization (WHO). Composite International Diagnostic Interview, version 2.1. Geneva: WHO; 1997.
22. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004;10:1-14.
23. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981;38:381-389.
24. Faraone SV, Wilens TE, Petty C, Antshel K, Spencer T, Biederman J. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addictions 2007;16(Suppl. 1):24-32; quiz 33-24.
25. Lecomte T, Mueser KT, MacEwan W, Thornton AE, Buchanan T, Bouchard V, Goldner E, et al. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J Nervous Mental Dis 2013;201:1085-1089.
26. Lecomte T, Mueser KT, MacEwan WG, Laferrière-Simard M-C, Thornton AE, Buchanan T, Goldner E, et al. Profiles of individuals seeking psychiatric help for psychotic symptoms linked to methamphetamine abuse-baseline results from the MAPS (methamphetamine and psychosis study). Ment Health Subst Use 2010;3:168-181.
27. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
28. Wilkinson GS. WRAT-3: Wide Range Achievement Test Administration Manual. Wilmington, DE: Wide Range; 1993.
29. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, Group H. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004;26:307-319.
30. Han B, Gfroerer JC, Colliver JD, Penne MA. Substance use disorder among older adults in the United States in 2020. Addiction 2009;104:88-96.
31. Semple SJ, Zians J, Grant I, Patterson TL. Impulsivity and methamphetamine use. J Subst Abuse Treat 2005;29:85-93.
32. Drumright LN, Little SJ, Strathdee SA, Slymen DJ, Araneta MR, Malcarne VL, Daar ES, Gorbach PM. Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr 2006;43:344-350.
33. Heijman T, Geskus RB, Davidovich U, Coutinho RA, Prins M, Stolte IG. Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era. AIDS 2012;26:489-495.
34. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005;78:125-134.
35. Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004;8:87-98.
36. Lim SH, Ostrow D, Stall R, Chmiel J, Herrick A, Shoptaw S, Kao U, et al. Changes in stimulant drug use over time in the MACS: evidence for resilience against stimulant drug use among men who have sex with men. AIDS Behav 2012;16:151-158.
37. Pilcher CD, Tien HC, Eron JJ Jr, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004;189:1785-1792.
38. Pao D, Fisher M, Hue S, Dean G, Murphy G, Cane PA, Sabin CA, Pillay D. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005;19:85-90.
39. Gavrilin MA, Mathes LE, Podell M. Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 2002;8:240-249.
40. Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care 2009;21:575-582.
41. Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, Myers HF, Longshore D. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav 2007;11:185-194.
42. Braine N, Des Jarlais DC, Goldblatt C, Zadoretzky C, Turner C. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. AIDS Educ Prev 2005;17:515-524.
43. Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep 2008;5:212-218.
44. Garofalo R, Mustanski BS, McKirnan DJ, Herrick A, Donenberg GR. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk. Arch Pediatr Adolesc Med 2007;161:591-596.
45. Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999;25:475-493.
46. Zule WA, Costenbader EC, Meyer WJ Jr, Wechsberg WM. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sex Transm Dis 2007;34:689-694.
47. Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre SL, et al. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol 2013;19:65-74.
48. Wutoh AK, Brown CM, Dutta AP, Kumoji EK, Clarke-Tasker V, Xue Z. Treatment perceptions and attitudes of older human immunodeficiency virus-infected adults. Res Soc Administrative Pharm 2005;1:60-76.
49. Zanjani F, Saboe K, Oslin D. Age difference in rates of mental health/substance abuse and behavioral care in HIV-positive adults. AIDS Patient Care STDS 2007;21:347-355.
50. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, Levine AJ, Durvasula RS. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol 2007;26:40-49.